Skip to main content

Table 2 Most common adverse events (regardless of the drug-relationship)

From: Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study

Adverse event

All grades N (%)

Grades 3/4 N (%)

 

Haematology

 

Anaemia

60 (44.8)

11 (8.2)

Leucopenia

23 (17.2)

7 (5.2)

Neutropenia

34 (25.4)

23 (17.2)

Thrombocytopenia

14 (10.4)

4 (3)

Febrile Neutropenia

5 (3.7)

4 (3)

 

NON HAEMATOLOGY

 

Asthenia, Fatigue

74 (55.2)

28 (20.9)

Constipation

55 (41.0)

11 (8.2)

Abdominal pain

21 (15.7)

7 (3)

Subocclusive syndrome

5 (3.7)

3 (2.1)

Neuropathy

10 (7.5)

1 (0.7)

Toxic death

0

0